Viewing StudyNCT00002238



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002238
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
Sponsor: Bayer
Organization: NIH AIDS Clinical Trials Information Service

Organization Data

Organization: NIH AIDS Clinical Trials Information Service
Class: INDUSTRY
Study ID: 002A
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Bayer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators